English
简体中文
Total: £ 56.28
Published Date: 2025-06-18 | Pages: 90 | Tables: 87 | Medical Care
The global market for Rare Gastrointestinal Diseases Treatment was valued at US$ 1421 million in the year 2024 and is projected to reach a revised size of US$ 2155 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Rare Gastrointestinal Diseases Treatment refers to the medical management of uncommon and often chronic or genetic disorders affecting the gastrointestinal (GI) tract, such as eosinophilic gastrointestinal disorders, intestinal pseudo-obstruction, short bowel syndrome, and microvillus inclusion disease. Treatment approaches vary based on the specific condition and may include dietary management, enzyme replacement, immunosuppressants, biologics, antibiotics, or surgical interventions. The aim is to control symptoms, improve quality of life, and address the underlying cause where possible.
North American market for Rare Gastrointestinal Diseases Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rare Gastrointestinal Diseases Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Rare Gastrointestinal Diseases Treatment in Eosinophilic Gastroenteritis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Rare Gastrointestinal Diseases Treatment include Takeda Pharmaceutical, Nestlé Health Science, Mirum Pharmaceutical, Recordati Rare Diseases, Zealand Pharma, Ironwood Pharmaceutical, Ipsen, Univar Solutions, Tilray Brand, 4D Molecular Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rare Gastrointestinal Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rare Gastrointestinal Diseases Treatment.
The Rare Gastrointestinal Diseases Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rare Gastrointestinal Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rare Gastrointestinal Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceutical
Nestlé Health Science
Mirum Pharmaceutical
Recordati Rare Diseases
Zealand Pharma
Ironwood Pharmaceutical
Ipsen
Univar Solutions
Tilray Brand
4D Molecular Therapeutics
Chiasma
Orphalan
Santhera Pharmaceutical
Segment by Type
Drugs
Device
Segment by Application
Eosinophilic Gastroenteritis
Hercksprung's Disease
Chronic Intestinal Pseudo-obstruction
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rare Gastrointestinal Diseases Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Gastrointestinal Diseases Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drugs
1.2.3 Device
1.3 Market by Application
1.3.1 Global Rare Gastrointestinal Diseases Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Eosinophilic Gastroenteritis
1.3.3 Hercksprung's Disease
1.3.4 Chronic Intestinal Pseudo-obstruction
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rare Gastrointestinal Diseases Treatment Market Perspective (2020-2031)
2.2 Global Rare Gastrointestinal Diseases Treatment Growth Trends by Region
2.2.1 Global Rare Gastrointestinal Diseases Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Rare Gastrointestinal Diseases Treatment Historic Market Size by Region (2020-2025)
2.2.3 Rare Gastrointestinal Diseases Treatment Forecasted Market Size by Region (2026-2031)
2.3 Rare Gastrointestinal Diseases Treatment Market Dynamics
2.3.1 Rare Gastrointestinal Diseases Treatment Industry Trends
2.3.2 Rare Gastrointestinal Diseases Treatment Market Drivers
2.3.3 Rare Gastrointestinal Diseases Treatment Market Challenges
2.3.4 Rare Gastrointestinal Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rare Gastrointestinal Diseases Treatment Players by Revenue
3.1.1 Global Top Rare Gastrointestinal Diseases Treatment Players by Revenue (2020-2025)
3.1.2 Global Rare Gastrointestinal Diseases Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Top Rare Gastrointestinal Diseases Treatment Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Rare Gastrointestinal Diseases Treatment Revenue
3.4 Global Rare Gastrointestinal Diseases Treatment Market Concentration Ratio
3.4.1 Global Rare Gastrointestinal Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Gastrointestinal Diseases Treatment Revenue in 2024
3.5 Global Key Players of Rare Gastrointestinal Diseases Treatment Head office and Area Served
3.6 Global Key Players of Rare Gastrointestinal Diseases Treatment, Product and Application
3.7 Global Key Players of Rare Gastrointestinal Diseases Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Gastrointestinal Diseases Treatment Breakdown Data by Type
4.1 Global Rare Gastrointestinal Diseases Treatment Historic Market Size by Type (2020-2025)
4.2 Global Rare Gastrointestinal Diseases Treatment Forecasted Market Size by Type (2026-2031)
5 Rare Gastrointestinal Diseases Treatment Breakdown Data by Application
5.1 Global Rare Gastrointestinal Diseases Treatment Historic Market Size by Application (2020-2025)
5.2 Global Rare Gastrointestinal Diseases Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Rare Gastrointestinal Diseases Treatment Market Size (2020-2031)
6.2 North America Rare Gastrointestinal Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Rare Gastrointestinal Diseases Treatment Market Size by Country (2020-2025)
6.4 North America Rare Gastrointestinal Diseases Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rare Gastrointestinal Diseases Treatment Market Size (2020-2031)
7.2 Europe Rare Gastrointestinal Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Rare Gastrointestinal Diseases Treatment Market Size by Country (2020-2025)
7.4 Europe Rare Gastrointestinal Diseases Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rare Gastrointestinal Diseases Treatment Market Size (2020-2031)
8.2 Asia-Pacific Rare Gastrointestinal Diseases Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Rare Gastrointestinal Diseases Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Rare Gastrointestinal Diseases Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rare Gastrointestinal Diseases Treatment Market Size (2020-2031)
9.2 Latin America Rare Gastrointestinal Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Rare Gastrointestinal Diseases Treatment Market Size by Country (2020-2025)
9.4 Latin America Rare Gastrointestinal Diseases Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rare Gastrointestinal Diseases Treatment Market Size (2020-2031)
10.2 Middle East & Africa Rare Gastrointestinal Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Rare Gastrointestinal Diseases Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Rare Gastrointestinal Diseases Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Details
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Rare Gastrointestinal Diseases Treatment Introduction
11.1.4 Takeda Pharmaceutical Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
11.1.5 Takeda Pharmaceutical Recent Development
11.2 Nestlé Health Science
11.2.1 Nestlé Health Science Company Details
11.2.2 Nestlé Health Science Business Overview
11.2.3 Nestlé Health Science Rare Gastrointestinal Diseases Treatment Introduction
11.2.4 Nestlé Health Science Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
11.2.5 Nestlé Health Science Recent Development
11.3 Mirum Pharmaceutical
11.3.1 Mirum Pharmaceutical Company Details
11.3.2 Mirum Pharmaceutical Business Overview
11.3.3 Mirum Pharmaceutical Rare Gastrointestinal Diseases Treatment Introduction
11.3.4 Mirum Pharmaceutical Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
11.3.5 Mirum Pharmaceutical Recent Development
11.4 Recordati Rare Diseases
11.4.1 Recordati Rare Diseases Company Details
11.4.2 Recordati Rare Diseases Business Overview
11.4.3 Recordati Rare Diseases Rare Gastrointestinal Diseases Treatment Introduction
11.4.4 Recordati Rare Diseases Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
11.4.5 Recordati Rare Diseases Recent Development
11.5 Zealand Pharma
11.5.1 Zealand Pharma Company Details
11.5.2 Zealand Pharma Business Overview
11.5.3 Zealand Pharma Rare Gastrointestinal Diseases Treatment Introduction
11.5.4 Zealand Pharma Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
11.5.5 Zealand Pharma Recent Development
11.6 Ironwood Pharmaceutical
11.6.1 Ironwood Pharmaceutical Company Details
11.6.2 Ironwood Pharmaceutical Business Overview
11.6.3 Ironwood Pharmaceutical Rare Gastrointestinal Diseases Treatment Introduction
11.6.4 Ironwood Pharmaceutical Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
11.6.5 Ironwood Pharmaceutical Recent Development
11.7 Ipsen
11.7.1 Ipsen Company Details
11.7.2 Ipsen Business Overview
11.7.3 Ipsen Rare Gastrointestinal Diseases Treatment Introduction
11.7.4 Ipsen Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
11.7.5 Ipsen Recent Development
11.8 Univar Solutions
11.8.1 Univar Solutions Company Details
11.8.2 Univar Solutions Business Overview
11.8.3 Univar Solutions Rare Gastrointestinal Diseases Treatment Introduction
11.8.4 Univar Solutions Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
11.8.5 Univar Solutions Recent Development
11.9 Tilray Brand
11.9.1 Tilray Brand Company Details
11.9.2 Tilray Brand Business Overview
11.9.3 Tilray Brand Rare Gastrointestinal Diseases Treatment Introduction
11.9.4 Tilray Brand Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
11.9.5 Tilray Brand Recent Development
11.10 4D Molecular Therapeutics
11.10.1 4D Molecular Therapeutics Company Details
11.10.2 4D Molecular Therapeutics Business Overview
11.10.3 4D Molecular Therapeutics Rare Gastrointestinal Diseases Treatment Introduction
11.10.4 4D Molecular Therapeutics Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
11.10.5 4D Molecular Therapeutics Recent Development
11.11 Chiasma
11.11.1 Chiasma Company Details
11.11.2 Chiasma Business Overview
11.11.3 Chiasma Rare Gastrointestinal Diseases Treatment Introduction
11.11.4 Chiasma Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
11.11.5 Chiasma Recent Development
11.12 Orphalan
11.12.1 Orphalan Company Details
11.12.2 Orphalan Business Overview
11.12.3 Orphalan Rare Gastrointestinal Diseases Treatment Introduction
11.12.4 Orphalan Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
11.12.5 Orphalan Recent Development
11.13 Santhera Pharmaceutical
11.13.1 Santhera Pharmaceutical Company Details
11.13.2 Santhera Pharmaceutical Business Overview
11.13.3 Santhera Pharmaceutical Rare Gastrointestinal Diseases Treatment Introduction
11.13.4 Santhera Pharmaceutical Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
11.13.5 Santhera Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Rare Gastrointestinal Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drugs
Table 3. Key Players of Device
Table 4. Global Rare Gastrointestinal Diseases Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Rare Gastrointestinal Diseases Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Rare Gastrointestinal Diseases Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Rare Gastrointestinal Diseases Treatment Market Share by Region (2020-2025)
Table 8. Global Rare Gastrointestinal Diseases Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Rare Gastrointestinal Diseases Treatment Market Share by Region (2026-2031)
Table 10. Rare Gastrointestinal Diseases Treatment Market Trends
Table 11. Rare Gastrointestinal Diseases Treatment Market Drivers
Table 12. Rare Gastrointestinal Diseases Treatment Market Challenges
Table 13. Rare Gastrointestinal Diseases Treatment Market Restraints
Table 14. Global Rare Gastrointestinal Diseases Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Rare Gastrointestinal Diseases Treatment Market Share by Players (2020-2025)
Table 16. Global Top Rare Gastrointestinal Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Gastrointestinal Diseases Treatment as of 2024)
Table 17. Ranking of Global Top Rare Gastrointestinal Diseases Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Rare Gastrointestinal Diseases Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Rare Gastrointestinal Diseases Treatment, Headquarters and Area Served
Table 20. Global Key Players of Rare Gastrointestinal Diseases Treatment, Product and Application
Table 21. Global Key Players of Rare Gastrointestinal Diseases Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rare Gastrointestinal Diseases Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Rare Gastrointestinal Diseases Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Rare Gastrointestinal Diseases Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Rare Gastrointestinal Diseases Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Rare Gastrointestinal Diseases Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Rare Gastrointestinal Diseases Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Rare Gastrointestinal Diseases Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Rare Gastrointestinal Diseases Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Rare Gastrointestinal Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Rare Gastrointestinal Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Rare Gastrointestinal Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Rare Gastrointestinal Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Rare Gastrointestinal Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Rare Gastrointestinal Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Rare Gastrointestinal Diseases Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Rare Gastrointestinal Diseases Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Rare Gastrointestinal Diseases Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Rare Gastrointestinal Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Rare Gastrointestinal Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Rare Gastrointestinal Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Rare Gastrointestinal Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Rare Gastrointestinal Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Rare Gastrointestinal Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Takeda Pharmaceutical Company Details
Table 47. Takeda Pharmaceutical Business Overview
Table 48. Takeda Pharmaceutical Rare Gastrointestinal Diseases Treatment Product
Table 49. Takeda Pharmaceutical Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025) & (US$ Million)
Table 50. Takeda Pharmaceutical Recent Development
Table 51. Nestlé Health Science Company Details
Table 52. Nestlé Health Science Business Overview
Table 53. Nestlé Health Science Rare Gastrointestinal Diseases Treatment Product
Table 54. Nestlé Health Science Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025) & (US$ Million)
Table 55. Nestlé Health Science Recent Development
Table 56. Mirum Pharmaceutical Company Details
Table 57. Mirum Pharmaceutical Business Overview
Table 58. Mirum Pharmaceutical Rare Gastrointestinal Diseases Treatment Product
Table 59. Mirum Pharmaceutical Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025) & (US$ Million)
Table 60. Mirum Pharmaceutical Recent Development
Table 61. Recordati Rare Diseases Company Details
Table 62. Recordati Rare Diseases Business Overview
Table 63. Recordati Rare Diseases Rare Gastrointestinal Diseases Treatment Product
Table 64. Recordati Rare Diseases Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025) & (US$ Million)
Table 65. Recordati Rare Diseases Recent Development
Table 66. Zealand Pharma Company Details
Table 67. Zealand Pharma Business Overview
Table 68. Zealand Pharma Rare Gastrointestinal Diseases Treatment Product
Table 69. Zealand Pharma Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025) & (US$ Million)
Table 70. Zealand Pharma Recent Development
Table 71. Ironwood Pharmaceutical Company Details
Table 72. Ironwood Pharmaceutical Business Overview
Table 73. Ironwood Pharmaceutical Rare Gastrointestinal Diseases Treatment Product
Table 74. Ironwood Pharmaceutical Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025) & (US$ Million)
Table 75. Ironwood Pharmaceutical Recent Development
Table 76. Ipsen Company Details
Table 77. Ipsen Business Overview
Table 78. Ipsen Rare Gastrointestinal Diseases Treatment Product
Table 79. Ipsen Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025) & (US$ Million)
Table 80. Ipsen Recent Development
Table 81. Univar Solutions Company Details
Table 82. Univar Solutions Business Overview
Table 83. Univar Solutions Rare Gastrointestinal Diseases Treatment Product
Table 84. Univar Solutions Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025) & (US$ Million)
Table 85. Univar Solutions Recent Development
Table 86. Tilray Brand Company Details
Table 87. Tilray Brand Business Overview
Table 88. Tilray Brand Rare Gastrointestinal Diseases Treatment Product
Table 89. Tilray Brand Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025) & (US$ Million)
Table 90. Tilray Brand Recent Development
Table 91. 4D Molecular Therapeutics Company Details
Table 92. 4D Molecular Therapeutics Business Overview
Table 93. 4D Molecular Therapeutics Rare Gastrointestinal Diseases Treatment Product
Table 94. 4D Molecular Therapeutics Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025) & (US$ Million)
Table 95. 4D Molecular Therapeutics Recent Development
Table 96. Chiasma Company Details
Table 97. Chiasma Business Overview
Table 98. Chiasma Rare Gastrointestinal Diseases Treatment Product
Table 99. Chiasma Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025) & (US$ Million)
Table 100. Chiasma Recent Development
Table 101. Orphalan Company Details
Table 102. Orphalan Business Overview
Table 103. Orphalan Rare Gastrointestinal Diseases Treatment Product
Table 104. Orphalan Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025) & (US$ Million)
Table 105. Orphalan Recent Development
Table 106. Santhera Pharmaceutical Company Details
Table 107. Santhera Pharmaceutical Business Overview
Table 108. Santhera Pharmaceutical Rare Gastrointestinal Diseases Treatment Product
Table 109. Santhera Pharmaceutical Revenue in Rare Gastrointestinal Diseases Treatment Business (2020-2025) & (US$ Million)
Table 110. Santhera Pharmaceutical Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Rare Gastrointestinal Diseases Treatment Picture
Figure 2. Global Rare Gastrointestinal Diseases Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Rare Gastrointestinal Diseases Treatment Market Share by Type: 2024 VS 2031
Figure 4. Drugs Features
Figure 5. Device Features
Figure 6. Global Rare Gastrointestinal Diseases Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Rare Gastrointestinal Diseases Treatment Market Share by Application: 2024 VS 2031
Figure 8. Eosinophilic Gastroenteritis Case Studies
Figure 9. Hercksprung's Disease Case Studies
Figure 10. Chronic Intestinal Pseudo-obstruction Case Studies
Figure 11. Rare Gastrointestinal Diseases Treatment Report Years Considered
Figure 12. Global Rare Gastrointestinal Diseases Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Rare Gastrointestinal Diseases Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Rare Gastrointestinal Diseases Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Rare Gastrointestinal Diseases Treatment Market Share by Players in 2024
Figure 16. Global Rare Gastrointestinal Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Rare Gastrointestinal Diseases Treatment Revenue in 2024
Figure 18. North America Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Rare Gastrointestinal Diseases Treatment Market Share by Country (2020-2031)
Figure 20. United States Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Rare Gastrointestinal Diseases Treatment Market Share by Country (2020-2031)
Figure 24. Germany Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Rare Gastrointestinal Diseases Treatment Market Share by Region (2020-2031)
Figure 32. China Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Rare Gastrointestinal Diseases Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Rare Gastrointestinal Diseases Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Rare Gastrointestinal Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Takeda Pharmaceutical Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
Figure 48. Nestlé Health Science Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
Figure 49. Mirum Pharmaceutical Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
Figure 50. Recordati Rare Diseases Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
Figure 51. Zealand Pharma Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
Figure 52. Ironwood Pharmaceutical Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
Figure 53. Ipsen Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
Figure 54. Univar Solutions Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
Figure 55. Tilray Brand Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
Figure 56. 4D Molecular Therapeutics Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
Figure 57. Chiasma Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
Figure 58. Orphalan Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
Figure 59. Santhera Pharmaceutical Revenue Growth Rate in Rare Gastrointestinal Diseases Treatment Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
